Emerging insights into enhancer RNAs: biogenesis, function, mechanism, and disease implication
Briefings in Bioinformatics · 2026
DOI: 10.1093/bib/bbaf700 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, 2026. Verfasst von Meiqian Qiu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Health Science Center, Ningbo University, 818 Fenghua Road, Jiangbei District, Ningbo, Zhejiang Province 315211, China. Hauptthemen laut MEDLINE: Enhancer RNAs, Neoplasms, Neurodegenerative Diseases, Enhancer Elements, Genetic. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China General Program, The Zhejiang Province Vanguard Goose-Leading Initiative, Ningbo Key Research and Development Program.
Abstract (Originalsprache)
In current years, the molecular mechanisms through which enhancer-derived noncoding RNAs—enhancer RNAs (eRNAs) have been increasingly elucidated. eRNAs are not mere as transcript products but considered as a marker of active enhancers, usually characterized by bidirectional transcription, lack of poly(A) tails and rapid degradation. Multiple lines of evidence have demonstrated eRNAs are involved in a number of regulation processes such as enhancer-promoter (E-P) looping, recruitment of transcriptional co-activators, regulation of RNA polymerase II (Pol II) pause release, and induction of R-loops, thereby enabling precise control of gene expression. Besides, the tissue-specific regulatory mechanisms of eRNAs in diverse diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders are being progressively elucidated, offering potential novel targets for precision diagnosis and therapy. This review systematically synthesizes recent advances in eRNA research, elucidating structural features, transcription processes, functions, regulatory mechanisms, detection, data resources, disease associations and proposing promising prospects for eRNA-targeted precision therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Health Science Center, Ningbo University, 818 Fenghua Road, Jiangbei District, Ningbo, Zhejiang Province 315211, China.
- Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, 59 Liuting Street, Haishu District, Ningbo, Zhejiang Province 315020, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Health Science Center, Ningbo University, 818 Fenghua Road, Jiangbei District, Ningbo, Zhejiang Province 315211, China.
ORCID-Profile: Qi Liao
Förderung
- National Natural Science Foundation of China General Program
- The Zhejiang Province Vanguard Goose-Leading Initiative
- Ningbo Key Research and Development Program
- Ningbo Natural Science Foundation
- Medical and Health Science and Technology Project of Zhejiang Province
- K.C. Wong Magna Fund of Ningbo University
Zitieren
APA
Qiu, M., Yu, X., Liu, H., Tao, Y., Huang, C., Xi, Y., & Liao, Q. (2026). Emerging insights into enhancer RNAs: biogenesis, function, mechanism, and disease implication. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf700
Vancouver
Qiu M, Yu X, Liu H, Tao Y, Huang C, Xi Y, et al. Emerging insights into enhancer RNAs: biogenesis, function, mechanism, and disease implication. Briefings in Bioinformatics. 2026. doi:10.1093/bib/bbaf700
BibTeX
@article{Qiu2026,
author = {Qiu, Meiqian and Yu, Xiuchong and Liu, Heting and Tao, Yuezhu and Huang, Chunhui and Xi, Yang and Liao, Qi},
title = {Emerging insights into enhancer RNAs: biogenesis, function, mechanism, and disease implication},
journal = {Briefings in Bioinformatics},
year = {2026},
doi = {10.1093/bib/bbaf700}
}
EUVIMED